BioInvest
Norstella, a global leader with end-to-end solutions that smooth access to life-saving therapies for patients, has announced the completion of its me...
November 02, 2022 | News
LAXAI Inc. (“LAXAI”) announced today that it has received a growth capital investment from SIGNET Healthcare Partners (“SIGNET”), a...
October 25, 2022 | News
Sumitovant Biopharma Ltd. ("Sumitovant"), in conjunction with parent company Sumitomo Pharma Co., Ltd. ("Sumitomo Pharma"), and Myovant Sciences ("Myovant"...
October 24, 2022 | News
Cordis is a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technologies. MedAlliance's innov...
October 19, 2022 | News
Kupando, a pioneering biopharmaceutical company developing TLR 4/7 agonists that stimulate innate immunity for use in oncology and infectious disease...
September 27, 2022 | News
Redbud Medicine is a next-generation clinical CRO focusing on science-based clinical development services. The company offers full-service development from...
September 13, 2022 | News
Through this funding, the company will be able to harness the full potential of its digital AI solution to read medical images including mammograms. The fu...
September 02, 2022 | News
Minderoo Foundation and Illumina, Inc. (NASDAQ: ILMN), today announced a 40 million Australian dollar (US $27.8 million) partnership th...
August 30, 2022 | News
Becton, Dickinson and Company (NYSE: BDX) (the "Company" or "BD") today announced the consideration payable in connection with its previously announce...
August 23, 2022 | News
Revenue of $1.72 billion represents 8% reported growth year-over-year; and up 13% on a core(1) basis. GAAP net income of $329 million with ea...
August 22, 2022 | News
This quarterly declaration is consistent with the dividend announcement made by the company in May 2022. Medtronic is a constituent of the S&P 500...
August 19, 2022 | News
In the first half of 2022, Henlius revenue reached approximately RMB1.289 billion, representing an increase of 103.5% YoY, which mainly benefited from...
August 19, 2022 | News
Minderoo Foundation and Illumina, Inc. (NASDAQ: ILMN), today announced a 40 million Australian dollar (US $27.8 million) partnership th...
August 19, 2022 | News
Highlights: Revenue of $1.72 billion represents 8% reported growth year-over-year; and up 13% on a core(1) basis. GAAP net income of $329 million ...
August 17, 2022 | News
Most Read
Bio Jobs
News